Literature DB >> 25091703

Interleukin-1β promotes the LC3-mediated secretory function of osteoclast precursors by stimulating the Ca²⁺-dependent activation of ERK.

Yeon-Ho Chung1, Bongkun Choi1, Da-Hyun Song1, Youngsup Song2, Sang-Wook Kang2, Seung-Yong Yoon3, Seong Who Kim4, Hyung Keun Lee5, Eun-Ju Chang6.   

Abstract

Bone resorption by osteoclasts requires the release of secretory lysosomes containing cathepsin K, which degrades the organic bone matrix. The activity of this secretory function is determined by the level of lipidation of microtubule-associated protein 1 light chain 3 (LC3). Although the inflammatory cytokine IL-1β increases osteoclast activity, the underlying mechanism(s) remains undefined. In our present study, we found that IL-1β accelerates the release of cathepsin K from osteoclast precursors by increasing the cleavage and lipidation of LC3 and the subsequent formation of lipid-bound LC3-II containing secretory lysosomes. IL-1β increased LC3-II formation within osteoclast precursors through a process that is dependent on increases in the intracellular Ca(2+) levels. In addition, IL-1β was found to act synergistically with RANKL to increase ERK activation in a Ca(2+)-dependent manner. More importantly, Atg7-deficient osteoclast precursors, which showed impaired lipidation of LC3-I, did not exhibit IL-1β-mediated increases in cathepsin K secretion. Thus, IL-1β promotes LC3-II formation through the Ca(2+)-dependent activation of ERK, which triggers the release of cathepsin K. These findings provide evidence for a molecular mechanism through which IL-1β enhances the secretory function of osteoclast precursors.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cathepsin K; IL-1β; Intracellular Ca(2+); LC3; Osteoclast

Mesh:

Substances:

Year:  2014        PMID: 25091703     DOI: 10.1016/j.biocel.2014.07.018

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal.

Authors:  Xiyan Li; Yuqi Guo; Wenbo Yan; Michael P Snyder; Xin Li
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

Review 2.  The Autophagy in Osteoimmonology: Self-Eating, Maintenance, and Beyond.

Authors:  Lan Xiao; Yin Xiao
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-23       Impact factor: 5.555

3.  Effects of Probiotic Culture Supernatant on Cariogenic Biofilm Formation and RANKL-Induced Osteoclastogenesis in RAW 264.7 Macrophages.

Authors:  Jae-In Jung; Seung-Min Baek; Trung Hau Nguyen; Jin Woo Kim; Chang-Ho Kang; Seonyoung Kim; Jee-Young Imm
Journal:  Molecules       Date:  2021-01-31       Impact factor: 4.411

Review 4.  A Review of Signaling Transduction Mechanisms in Osteoclastogenesis Regulation by Autophagy, Inflammation, and Immunity.

Authors:  Xishuai Tong; Gengsheng Yu; Xiaohui Fu; Ruilong Song; Jianhong Gu; Zongping Liu
Journal:  Int J Mol Sci       Date:  2022-08-30       Impact factor: 6.208

5.  Microtubule-associated protein light chain 3 is involved in melanogenesis via regulation of MITF expression in melanocytes.

Authors:  Woo Jin Yun; Eun-Young Kim; Ji-Eun Park; Soo Youn Jo; Seung Hyun Bang; Eun-Ju Chang; Sung Eun Chang
Journal:  Sci Rep       Date:  2016-01-27       Impact factor: 4.379

Review 6.  Roles of Mitogen-Activated Protein Kinases in Osteoclast Biology.

Authors:  Kyunghee Lee; Incheol Seo; Mun Hwan Choi; Daewon Jeong
Journal:  Int J Mol Sci       Date:  2018-10-01       Impact factor: 5.923

7.  Interleukin‑17A facilitates osteoclast differentiation and bone resorption via activation of autophagy in mouse bone marrow macrophages.

Authors:  Lu Song; Jingyi Tan; Zhongxiu Wang; Peihui Ding; Qi Tang; Mengjiao Xia; Yingming Wei; Lili Chen
Journal:  Mol Med Rep       Date:  2019-04-11       Impact factor: 2.952

8.  Nepetin inhibits osteoclastogenesis by inhibiting RANKL-induced activation of NF-κB and MAPK signalling pathway, and autophagy.

Authors:  Binxiang Chu; Shenao Chen; Xiaohe Zheng; Jiajing Ye; Xu Cheng; Liwei Zhang; Di Guo; Peng Wang; Dun Hong; Zhenghua Hong
Journal:  J Cell Mol Med       Date:  2020-11-01       Impact factor: 5.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.